GSK Scientists Knew About Zantac’s Cancer Risks For Forty Years
By Tyler Durden Three years after the Food & Drug Administration (FDA) pulled GSK Plc’s heartburn drug Zantac off the market due to suspected links to cancer, and just two weeks before the trial begins of a man who alleges he developed bladder cancer after…
